We are live on ! Find out more
GCM

Gruss Capital Management Portfolio holdings

AUM $715M
1-Year Est. Return 9.91%
This Fund
S&P 500
This Quarter Est. Return
-11.99%
1 Year Est. Return
+9.91%
3 Year Est. Return
+62.11%
5 Year Est. Return
+60.72%
10 Year Est. Return
AUM
$3.17B
AUM Growth
+$341M
Cap. Flow
+$605M
Cap. Flow %
19.11%
Top 10 Hldgs %
56.21%
Holding
102
New
32
Increased
14
Reduced
13
Closed
23

Sector Composition

Rank Sector Weight
1 Communication Services 12.93%
2 Financials 4.8%
3 Technology 4.43%
4 Consumer Discretionary 3.14%
5 Energy 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRSHU
51
DELISTED
Gores Holdings, Inc.
GRSHU
$4.04M 0.13%
+400,000
New +$4.03M
BLVDU
52
DELISTED
Boulevard Acquisition Corp. II
BLVDU
$3.99M 0.13%
+400,000
New +$3.99M
ELECU
53
DELISTED
Electrum Special Acquisition Corporation
ELECU
$3.95M 0.12%
400,000
TFCF
54
PUT
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$3.79M 0.12%
+140,000
New +$4.15M
TRQ
55
DELISTED
Turquoise Hill Resources Ltd
TRQ
$3.19M 0.1%
125,000
-193,000
-61% -$6.14M
EAGLU
56
DELISTED
Double Eagle Acquisition Corp.
EAGLU
$3.04M 0.1%
+300,000
New +$3.04M
CASC
57
DELISTED
Cascadian Therapeutics, Inc.
CASC
$3.03M 0.1%
184,333
CSBK
58
DELISTED
Clifton Bancorp Inc.
CSBK
$2.96M 0.09%
213,452
-136,548
-39% -$1.9M
CCXI
59
DELISTED
ChemoCentryx, Inc.
CCXI
$2.92M 0.09%
482,000
LILA icon
60
Liberty Latin America Class A
LILA
$1.64B
$2.79M 0.09%
+129,316
New +$3.29M
RPRX
61
DELISTED
Repros Therapeutics Inc.
RPRX
$2.26M 0.07%
304,000
TTPH
62
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.24M 0.07%
+15,000
New +$11M
ADVM
63
DELISTED
Adverum Biotechnologies
ADVM
$2.14M 0.07%
+26,000
New +$3.32M
CVO
64
DELISTED
Cenevo, Inc.
CVO
$2.07M 0.07%
137,500
+25,000
+22% +$354K
PACEU
65
DELISTED
Pace Holdings Corp.
PACEU
$2.04M 0.06%
+200,000
New +$2.03M
QLTI
66
DELISTED
QLT Inc
QLTI
$2.04M 0.06%
765,000
FRP
67
DELISTED
Fairpoint Communications, Inc.
FRP
$2M 0.06%
130,000
AVEO
68
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.89M 0.06%
156,383
KIN
69
DELISTED
Kindred Biosciences, Inc.
KIN
$1.72M 0.05%
330,000
KMI.WS
70
DELISTED
Kinder Morgan Inc
KMI.WS
$1.24M 0.04%
+1,350,000
New +$2.08M
GCVRZ
71
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$1.05M 0.03%
5,500,000
+1,500,000
+38% +$510K
KERX
72
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.01M 0.03%
288,000
+50,000
+21% +$335K
SPHS
73
DELISTED
Sophiris Bio, Inc.
SPHS
$457K 0.01%
538,000
BWXT icon
74
BWX Technologies
BWXT
$15.5B
-1,048,480
Closed -$19.9M
GHC icon
75
Graham Holdings Company
GHC
$5.1B
-40,382
Closed -$26.2M

Similar funds

Gruss Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Gruss Capital Management held 102 positions worth $3.17B, up 12% from $2.82B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Gruss Capital Management deployed $605M of net new capital in Q3 2015, opening 32 new positions and adding to 14 existing holdings. Its largest new stake was HP: 4,404,000 shares worth $51.2M.

By sector, the portfolio is most concentrated in Communication Services at 13% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Forest City Realty Trust, Inc., an estimated $43.1M trimmed.

  • Gruss Capital Management's largest Q3 2015 buy was HP: 4,404,000 shares worth $51.2M.
  • Gruss Capital Management added most to TIME WARNER CABLE INC NEW COM STK in Q3 2015, an estimated $108M increase.
  • Gruss Capital Management's biggest Q3 2015 reduction was Forest City Realty Trust, Inc., cutting an estimated $43.1M.
  • Gruss Capital Management fully exited Juniper Networks in Q3 2015, selling an estimated $51.8M.
  • Gruss Capital Management's ten largest holdings make up 56% of its $3.17B portfolio in Q3 2015.
  • Gruss Capital Management opened 32 new positions and closed 23 in Q3 2015.
  • Gruss Capital Management's portfolio value rose 12% quarter-over-quarter to $3.17B.

Based on Gruss Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.